Imatinib radiosensitizes bladder cancer by targeting homologous recombination.

@article{Qiao2013ImatinibRB,
  title={Imatinib radiosensitizes bladder cancer by targeting homologous recombination.},
  author={Boling Qiao and Martin Kerr and Blaz Groselj and Mark T. W. Teo and Margaret A Knowles and Robert G. Bristow and Roger M. Phillips and Anne E Kiltie},
  journal={Cancer research},
  year={2013},
  volume={73 5},
  pages={1611-20}
}
Radiotherapy is a major treatment modality used to treat muscle-invasive bladder cancer, with patient outcomes similar to surgery. However, radioresistance is a significant factor in treatment failure. Cell-free extracts of muscle-invasive bladder tumors are defective in nonhomologous end-joining (NHEJ), and this phenotype may be used clinically by combining radiotherapy with a radiosensitizing drug that targets homologous recombination, thereby sparing normal tissues with intact NHEJ. The… CONTINUE READING
Highly Cited
This paper has 40 citations. REVIEW CITATIONS
Recent Discussions
This paper has been referenced on Twitter 1 time over the past 90 days. VIEW TWEETS
15 Citations
36 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 15 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 36 references

Similar Papers

Loading similar papers…